Clik here to view.
CPIP Scholars File Amicus Brief Urging Consideration of Claimed Inventions as...
Last week, CPIP Senior Scholar Adam Mossoff and I filed an amicus brief on behalf of 15 law professors, including CPIP’s Devlin Hartline, Chris Holman, Sean O’Connor, Kristen Osenga, and Mark Schultz....
View ArticleClik here to view.
An Ever-Weakening Patent System is Threatening the Future of American Innovation
Over the past ten years, the United States patent system has been transformed by new legislation, regulatory actions, and numerous decisions by the Supreme Court addressing nearly every area of patent...
View ArticleClik here to view.
CPIP Scholars File Amicus Brief Urging Supreme Court to Fix Section 101
On December 4, 2017, CPIP Founder Adam Mossoff and CPIP John F. Witherspoon Legal Fellow David Lund filed an amicus brief urging the Supreme Court to grant certiorari in RecogniCorp. v. Nintendo. The...
View ArticleClik here to view.
CPIP Scholars Ask Federal Circuit to Fix Patent Eligibility Doctrine in...
Last week, a group of CPIP scholars filed an amicus brief in Cleveland Clinic Foundation v. True Health Diagnostics, a case currently on appeal to the U.S. Court of Appeals for the Federal Circuit. The...
View ArticleClik here to view.
CPIP Scholars To Federal Circuit: Protect Innovation in the Life Sciences
Last week, a group of CPIP scholars—Chris Holman, David Lund, Adam Mossoff, and Kristen Osenga—filed an amicus brief in Natural Alternatives International v. Creative Compounds, a case currently on...
View ArticleClik here to view.
The Value of Public Data: Update to “Turning Gold to Lead”
By Kevin Madigan & Adam Mossoff A key value in the empirical work done in the social sciences and in the STEM fields is that data is made public and available for review, testing, and confirmation....
View ArticleClik here to view.
Rep. Massie Introduces New Legislation to Restore America’s Patent System
Yesterday, Representative Thomas Massie introduced the Restoring America’s Leadership in Innovation Act of 2018 (H.R. 6264). This legislation would reverse many of the harms that have been caused by...
View ArticleClik here to view.
“No Combination Drug Patents Act” Stalls, but Threats to Innovation Remain
By Kevin Madigan & Sean O’Connor This week, the Senate Judiciary Committee was to mark up a bill limiting patent eligibility for combination drug patents—new forms, uses, and administrations of FDA...
View ArticleClik here to view.
CPIP Roundup – August 31, 2020
Greetings from CPIP Executive Director Sean O’Connor August has seen the beginning of a highly unusual school year, but I hope everyone is continuing to stay safe. And, since even a pandemic can’t...
View ArticleClik here to view.
Rethinking § 101: Professor Talha Syed Takes a Different Look at Subject...
The following post comes from Colin Kreutzer, a 2E at Scalia Law and a Research Assistant at CPIP. By Colin Kreutzer When most people think of patentability requirements, they think of whether an...
View Article
